The Canadian Association of Radiopharmaceutical Scientists (CARS) is closely monitoring the global developments related to the COVID-19 and potential challenges this will have on the field of radiopharmaceutical preparation and manufacturing.
To our knowledge, as of today no disruption in the regular operations in manufacturing of radiopharmaceuticals is reported.
Please read the full message of CARS President CARS_COVID19 response
Join our forum to follow our discussions regarding the latest updates, how the community responds to the unprecedented situation.
